Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002282 |
---|---|
Receipt number | R000002793 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for patients with sarcoma. |
Date of disclosure of the study information | 2009/08/03 |
Last modified on | 2019/10/30 13:18:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/08/02 13:01:23 | ||
2 | Update | 2011/09/26 11:28:35 | UMIN ID1 |
|
3 | Update | 2011/09/28 10:34:43 | Recruitment status |
|
4 | Update | 2011/11/04 14:19:10 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name Name of person sending information Name of person sending information Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2014/07/08 15:09:10 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
6 | Update | 2014/12/08 14:24:56 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
7 | Update | 2014/12/10 12:49:04 | Key secondary outcomes |
|
8 | Update | 2019/01/07 10:48:56 | Recruitment status |
|
9 | Update | 2019/10/30 13:18:14 | Recruitment status Date of IRB |